SINTX TECHNOLOGIES, INC.

SINT Healthcare Medical Devices

SINTX TECHNOLOGIES, INC.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 million, down 64.7% from fiscal 2024. In the quarter to June 2026, revenue grew 199.3%, EPS grew 17.6%, free cash flow fell 38.6% and total debt fell 6.42%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.74 0.03 −1.69%
Market cap
$13.4M
P/E
0.0×
Fwd P/E
−1.0×
Dividend yield
—
F-score
2/9
Altman Z
−45.42
Beneish M
−3.03
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
2 2 2 2

+8 more TTM periods

ROE
(429.26%) (503.49%) (500.75%) (343.31%)
ROA
(192.88%) (182.89%) (180.59%) (146.14%)
ROIC
(548.06%) 0.00% 0.00% 0.00%
Return on Tangible Assets
(422.27%) (3,106.17%) (713.87%) (466.04%)
Average Days of Receivables
90.29 129.12 63.82 34.49
Free Cash Flow per Share
(2.13) (2.38) (3.03) (2.46)
Free Cash Flow
(10.34) (9.54) (8.41) (7.29)
Other line items

Show all line items

Columns are period end dates